心血管病学进展2024,Vol.45Issue(1) :52-56.DOI:10.16806/j.cnki.issn.1004-3934.2024.01.014

肿瘤相关高血压的血压管理的研究进展

Blood Pressure Management of Tumor-Associated Hypertension

蒋弼瀛 黄佳宇 陈文佳
心血管病学进展2024,Vol.45Issue(1) :52-56.DOI:10.16806/j.cnki.issn.1004-3934.2024.01.014

肿瘤相关高血压的血压管理的研究进展

Blood Pressure Management of Tumor-Associated Hypertension

蒋弼瀛 1黄佳宇 1陈文佳1
扫码查看

作者信息

  • 1. 哈尔滨医科大学附属第一医院心内科,黑龙江哈尔滨 150001
  • 折叠

摘要

近年来众多研究证实长期使用抗高血压药治疗及高血压本身会导致肿瘤发病风险增加,同时在应用抗肿瘤药过程中也会导致高血压的发生.然而,目前仍缺乏有关肿瘤患者合并高血压的最佳血压管理方法.现强调高血压与肿瘤之间的关系,并讨论接受抗肿瘤药治疗的肿瘤患者的血压控制目标以及评估和管理策略.肿瘤患者的血压达标对于降低抗肿瘤治疗引起的心脏毒性和心血管疾病的风险至关重要.

Abstract

In recent years,many studies have confirmed that long-term use of anti-hypertensive drugs and hypertension itself will lead to an increased risk of tumor,at the same time,it will also lead to the occurrence of hypertension during the use of anti-tumor drugs.However,there is still a lack of optimal blood pressure management methods for cancer patients with hypertension.This review highlights the relationship between hypertension and tumor and discusses the objectives of blood pressure control,evaluation and management strategies for tumor patients treated with anti-tumor drugs.It is of utmost importance to maintain optimal blood pressure control in the tumor patients to reduce the risk of cardiotoxicity and cardiovascular disease caused by anti-tumor therapy.

关键词

高血压/肿瘤/抗肿瘤治疗/血压管理

Key words

Hypertension/Tumor/Anti-tumor therapy/Blood pressure management

引用本文复制引用

基金项目

国家自然科学基金(81800419)

黑龙江省自然科学基金青年科学基金(QC2017104)

哈尔滨医科大学附属第一医院科研创新基金(2019M08)

出版年

2024
心血管病学进展
成都市心血管病研究所,成都市第三人民医院

心血管病学进展

CSTPCD
影响因子:0.932
ISSN:1004-3934
参考文献量34
段落导航相关论文